NIKKEI 225
27,819.33 -180.67 (-0.65%) HANG SENG
20,082.43 +471.59 (+2.40%) CRUDE OIL
94.43 +2.50 (+2.72%) GOLD FUTURES
1,806.10 -7.60 (-0.42%) DOW
33,453.25 +143.74 (+0.43%) BTC-GBP
19,916.06 +146.01 (+0.74%)
COMPASS Pathways plc (CMPS)
| Previous close | 19.73 |
| Open | 19.94 |
| Bid | 18.10 x 900 |
| Ask | 18.25 x 1200 |
| Day's range | 17.82 - 20.09 |
| 52-week range | 6.54 - 49.51 |
| Volume | |
| Avg. volume | 348,941 |
| Market cap | 746.959M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.68 |
| Earnings date | 09 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 68.00 |
- Zacks
Wall Street Analysts See a 289% Upside in COMPASS Pathways PLC Sponsored ADR (CMPS): Can the Stock Really Move This High?
The consensus price target hints at a 288.6% upside potential for COMPASS Pathways PLC Sponsored ADR (CMPS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Motley Fool
COMPASS Pathways plc (CMPS) Q2 2022 Earnings Call Transcript
Again, my name is Steve Schultz, senior vice president of investor relations at COMPASS Pathways. The call is being recorded and will be available on the COMPASS Pathways' Investor Relations website shortly after the conclusion of the call.
- Globe Newswire
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights
LONDON, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Highlights: Kabir Nath appointed as Chief Executive Officer Phase III program submitted to FDA and under reviewCOMP360 phase II study in anorexia nervosa launchedCash position at 30 June 2022 of $207.2 millionConference call today at 8:00am ET (1:00pm UK) COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results
